UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Public health implications of antiretroviral therapy and HIV drug resistance

JAMA : the journal of the American Medical Association, 1998-06, Vol.279 (24), p.1977

1998

Volltextzugriff (PDF)

HIV-1 subtype distribution and the problem of drug resistance

AIDS (London), 2004-06, Vol.18 Suppl 3 (Supplement 3), p.S63-S68

Wainberg, Mark A

2004

Volltextzugriff (PDF)

Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout

AIDS (London), 2018-08, Vol.32 (13), p.1773-1780

2018

Volltextzugriff (PDF)

Transmission networks of drug resistance acquired in primary/early stage HIV infection

AIDS (London), 2008-11, Vol.22 (18), p.2509-2515

2008

Volltextzugriff (PDF)

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline

AIDS (London), 2013-03, Vol.27 (6), p.879-887

2013

Volltextzugriff (PDF)

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

AIDS (London), 2003-01, Vol.17 (1), p.F1-F5

2003

Volltextzugriff (PDF)

Can the further clinical development of bevirimat be justified?

AIDS (London), 2010-03, Vol.24 (5), p.773-774

2010

Volltextzugriff (PDF)

Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression

Journal of Virology, 2005-01, Vol.79 (1), p.124-131

2005

Volltextzugriff (PDF)

Perspectives on antiviral drug development

Antiviral research, 2009, Vol.81 (1), p.1-5

Wainberg, Mark A.

2009

Volltextzugriff (PDF)

Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs

The Journal of infectious diseases, 2013-06, Vol.207 (suppl_2), p.S101-S106

2013

Volltextzugriff (PDF)

HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors

Journal of acquired immune deficiency syndromes (1999), 2003-09, Vol.34 Suppl 1, p.S2-S7

Wainberg, Mark A

2003

Volltextzugriff (PDF)

Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives

Antiviral research, 2007-12, Vol.76 (3), p.203-221

2007

Volltextzugriff (PDF)

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination

AIDS (London), 2011-08, Vol.25 (13), p.1585-1594

2011

Volltextzugriff (PDF)

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

AIDS (London), 2010-09, Vol.24 (14), p.2171-2179

2010

Volltextzugriff (PDF)

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance

Journal of antimicrobial chemotherapy, 2003-02, Vol.51 (2), p.229-240

2003

Volltextzugriff (PDF)

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection

AIDS (London), 2004-08, Vol.18 (12), p.1653-1660

2004

Volltextzugriff (PDF)

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Journal of Virology, 2002-02, Vol.76 (4), p.1753-1761

2002

Volltextzugriff (PDF)

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

Viruses, 2010-11, Vol.2 (11), p.2493-2508

2010

Volltextzugriff (PDF)

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration

CPT: pharmacometrics and systems pharmacology, 2017-07, Vol.6 (7), p.469-476

2017

Volltextzugriff (PDF)

Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data

AIDS (London), 2011-10, Vol.25 (16), p.2019-2026

2011

Volltextzugriff (PDF)

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir

HIV/AIDS (Auckland), 2013-01, Vol.5 (default), p.41-49

Wainberg, Mark A

2013

Volltextzugriff (PDF)

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence

AIDS reviews, 2008-10, Vol.10 (4), p.212-223

2008

Volltextzugriff (PDF)

Generic HIV Drugs — Enlightened Policy for Global Health

The New England journal of medicine, 2005-02, Vol.352 (8), p.747-750

Wainberg, Mark A

2005

Volltextzugriff (PDF)

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase

Antimicrobial agents and chemotherapy, 2003-11, Vol.47 (11), p.3377-3383

2003

Volltextzugriff (PDF)

1 – 25 von 495

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(410)

Publikationsform

Artikel
(494)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(397)
Life Sciences & Biomedicine
(383)
Humans
(312)
Aids/hiv
(239)
Virology
(196)
Biological And Medical Sciences
(182)
Hiv-1 - Genetics
(151)
Human Immunodeficiency Virus 1
(149)
Medical Sciences
(128)
Infectious Diseases
(127)
Immunology
(120)
Hiv-1 - Drug Effects
(119)
Animals
(111)
Microbiology
(104)
Mutation
(80)
Antiviral Agents
(79)
Molecular Sequence Data
(75)
Pharmacology. Drug Treatments
(74)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(73)
Cell Line
(70)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Public health implications of antiretroviral therapy and HIV drug resistance

HIV-1 subtype distribution and the problem of drug resistance

Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout

Transmission networks of drug resistance acquired in primary/early stage HIV infection

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

Can the further clinical development of bevirimat be justified?

Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression

Perspectives on antiviral drug development

Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs

HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors

Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration

Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence

Generic HIV Drugs — Enlightened Policy for Global Health

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase

Suchergebnisse filtern